Prianka Singh

2.0k total citations
33 papers, 215 citations indexed

About

Prianka Singh is a scholar working on Oncology, Economics and Econometrics and Surgery. According to data from OpenAlex, Prianka Singh has authored 33 papers receiving a total of 215 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 11 papers in Economics and Econometrics and 10 papers in Surgery. Recurrent topics in Prianka Singh's work include Atrial Fibrillation Management and Outcomes (10 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Economic and Financial Impacts of Cancer (6 papers). Prianka Singh is often cited by papers focused on Atrial Fibrillation Management and Outcomes (10 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Economic and Financial Impacts of Cancer (6 papers). Prianka Singh collaborates with scholars based in United States, United Kingdom and Germany. Prianka Singh's co-authors include Beata Korytowsky, Amanda Bruno, Neehar D. Parikh, Lre Bereznicki, Gregory M. Peterson, Bryan Bennett, James W. Shaw, Jaffer A. Ajani, Andrew D. Norden and Lien Vo and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Prianka Singh

30 papers receiving 211 citations

Peers

Countries citing papers authored by Prianka Singh

Since Specialization

Citations

This map shows the geographic impact of Prianka Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prianka Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prianka Singh more than expected).

Fields of papers citing papers by Prianka Singh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prianka Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prianka Singh. The network helps show where Prianka Singh may publish in the future.

Co-authorship network of co-authors of Prianka Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Prianka Singh. A scholar is included among the top collaborators of Prianka Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prianka Singh. Prianka Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integra's legacy unveiled: expert panel recommendations summarizing 25 years of experience in head and neck reconstruction 2025 ·JPRAS Open ·(unknown), (unknown), Riccardo E. Giunta, (unknown), Prianka Singh, (unknown)	1
2	CO159 Treatment Characteristics of Adults with Hepatocellular Carcinoma after Curative Resection or Ablation: A Multinational, Retrospective Chart Review Study 2023 ·Value in Health ·Prianka Singh, Ashley Martin, (unknown), (unknown), Ronald Matteotti	1
3	POSA39 Cost-Effectiveness Analysis of Nivolumab for the Adjuvant Treatment of Patients with Resected Esophageal Cancer (EC) or Gastroesophageal Junction Cancer (GEJC) in Canada 2022 ·Value in Health ·(unknown), (unknown), Edna Keeney, Howard Thom, Prianka Singh, (unknown), (unknown)	2
4	Disease-free survival as a surrogate endpoint for overall survival in adults with resectable esophageal or gastroesophageal junction cancer: A correlation meta-analysis 2022 ·European Journal of Cancer ·Jaffer A. Ajani, (unknown), Prianka Singh, Murat Kurt, (unknown), (unknown), Steve Kanters	14
5	Real-world study of the impact of recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) on quality of life and productivity in Europe 2021 ·BMC Cancer ·Prianka Singh, Bryan Bennett, Tom Bailey, Gavin Taylor‐Stokes, (unknown), (unknown), (unknown), Chris Curtis	11
6	Real-World Treatment Patterns and Outcomes in Patients with Head and Neck Cancer: Point-in-Time Survey of Oncologists in Italy and Spain 2021 ·Advances in Therapy ·Prianka Singh, (unknown), Bryan Bennett, J. Hall, (unknown), (unknown), (unknown), (unknown)	9
7	Checkmate 577:Health-related quality of life (HRQoL) in a randomized, double-blind phase III study of nivolumab (NIVO) versus placebo (PBO) as adjuvant treatment in patients (pts) with resected esophageal or gastroesophageal junction cancer (EC/GEJC). 2021 ·Journal of Clinical Oncology ·Eric Van Cutsem, Prianka Singh, James M. Cleary, Ronan J. Kelly, Markus Moehler, Jarosław Kużdżał, Guillermo Méndez, Satoru Motoyama, Elena Elimova, Cecile Grootscholten, Xiaowu Sun, Fiona Taylor, Rachael Lawrance, (unknown), (unknown), Jenny Zhang, Steven I. Blum, Jaffer A. Ajani	2
8	Treatment patterns and outcomes for patients with newly diagnosed glioblastoma multiforme: a retrospective cohort study 2021 ·CNS Oncology ·Srinivas Annavarapu, (unknown), Trang T. Pham, Kalatu Davies, Prianka Singh, Nicholas J. Robert	10
9	PCN295 Health State Utility Values By Time to Death in Recurrent or Metastatic Squamous-Cell Carcinoma of the Head and Neck 2020 ·Value in Health ·(unknown), Andrew Trigg, Michael DeRosa, Prianka Singh, Bryan Bennett, Fiona Taylor, Kim Cocks	0
10	Treatment Patterns and Economic Burden by Lines of Therapy Among Patients with Advanced Hepatocellular Carcinoma Treated with Systemic Cancer Therapy 2019 ·Journal of Gastrointestinal Cancer ·Machaon Bonafede, Beata Korytowsky, Prianka Singh, Qian Cai, Katherine Cappell, (unknown), (unknown), Neehar D. Parikh	14
11	Real-world treatment patterns, cost of care and effectiveness of therapies for patients with squamous cell carcinoma of head and neck pre and post approval of immuno-oncology agents 2019 ·Journal of Medical Economics ·(unknown), Jonathan Kish, Beata Korytowsky, (unknown), Prianka Singh, James W. Shaw, Bruce A. Feinberg	2
12	Cost Of Treatment-Related Adverse Events (TRAES) In Second-Line (2l) Advanced Hepatocellular Carcinoma (AHCC): Match Adjusted Indirect Comparison (MAIC) Of Nivolumab And Regorafenib 2017 ·Value in Health ·(unknown), David D. Stenehjem, (unknown), Prianka Singh, (unknown), (unknown), Thomas Wısnıewskı, Prakash Prakash, Pragya Shukla, Beata Korytowsky, (unknown)	2
13	The Novel Generation And Validation of Survival Curves In Oncology Utilizing Electronic Medical Records Linked To Point of Service Claims Data 2017 ·Value in Health ·(unknown), Beata Korytowsky, Prianka Singh, Parvati Dev, (unknown), (unknown)	2
14	Treatment and discharge patterns among patients hospitalized with non-valvular atrial fibrillation transitioning from the inpatient to outpatient setting 2017 ·Current Medical Research and Opinion ·Henry J. Henk, Feng Cao, (unknown), (unknown), Prianka Singh, Jack Mardekian, (unknown), (unknown), (unknown), George H. Sands, Shalabh Singhal, Jeffrey Trocio, Lien Vo	1
15	HOUT-19. DEVELOPMENT OF A NOVEL BURDEN SURVEY FOR CAREGIVERS OF GLIOBLASTOMA MULTIFORME (GBM) PATIENTS 2017 ·Neuro-Oncology ·(unknown), Hillevi Bauer, Junjie Ma, (unknown), (unknown), Prianka Singh, Beata Korytowsky, Elizabeth Wilson, Nicole E. Willmarth, Adam L. Cohen, Howard Colman, David D. Stenehjem, Diana Brixner	0
16	Warfarin Management and Outcomes in Patients with Nonvalvular Atrial Fibrillation Within an Integrated Health Care System 2017 ·Journal of Managed Care & Specialty Pharmacy ·Jaejin An, Fang Niu, Chengyi Zheng, Nazia Rashid, Robert A. Mendes, Diana Dills, Lien Vo, Prianka Singh, Amanda Bruno, (unknown), (unknown), (unknown), (unknown)	13
17	Treatment and Discharge Patterns Among Patients Hospitalized With Nonvalvular Atrial Fibrillation (NVAF) Who Transition From the Inpatient to Outpatient Setting 2015 ·CHEST Journal ·Jeffrey Trocio, Amanda Bruno, (unknown), (unknown), Prianka Singh, Jack Mardekian, (unknown), (unknown), (unknown), Henry J. Henk, Lien Vo	0
18	Warfarin time in therapeutic range and its impact on healthcare resource utilization and costs among patients with nonvalvular atrial fibrillation 2015 ·Current Medical Research and Opinion ·Steve Deitelzweig, Michael A. Evans, Eric Hillson, Jeffrey Trocio, Amanda Bruno, (unknown), Melissa Lingohr-Smith, Prianka Singh, Jay Lin	8
19	Comparison of Short-Term Bleeding-Related Health Care Utilization and Costs Among Treatment-Naïve Nonvalvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban, or Warfarin 2015 ·CHEST Journal ·Alpesh Amin, Allison Keshishian, Lin Xie, Onur Başer, (unknown), Lien Vo, Prianka Singh, Amanda Bruno, Jack Mardekian, (unknown), Shalabh Singhal, (unknown), (unknown), Jeffrey Trocio	2
20	Evaluation of antithrombotic usage for atrial fibrillation in aged care facilities 2010 ·Journal of Clinical Pharmacy and Therapeutics ·Prianka Singh, (unknown), Gregory M. Peterson, Lre Bereznicki	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact